$19 Billion is the total value of Point72 Asset Management, L.P.'s 917 reported holdings in Q4 2019. The portfolio turnover from Q3 2019 to Q4 2019 was 0.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
PTCT | PTC THERAPEUTICS INCcall | $19,212,000 | +42.0% | 400,000 | 0.0% | 0.10% | +21.7% | |
STKL | SUNOPTA INC | $13,809,000 | +38.9% | 5,523,477 | 0.0% | 0.07% | +19.7% | |
CME | CME GROUP INC | $12,050,000 | -5.0% | 60,032 | 0.0% | 0.06% | -19.2% | |
APVO | APTEVO THERAPEUTICS INC | $1,604,000 | +11.2% | 2,450,000 | 0.0% | 0.01% | -11.1% | |
IDYA | IDEAYA BIOSCIENCES INC | $1,482,000 | -16.7% | 197,615 | 0.0% | 0.01% | -27.3% | |
KALA | KALA PHARMACEUTICALS INC | $1,144,000 | -3.1% | 310,000 | 0.0% | 0.01% | -14.3% | |
EPHE | ISHARES TRmsci philips etf | $343,000 | +2.4% | 10,000 | 0.0% | 0.00% | 0.0% | |
GREK | GLOBAL X FDSmsci greece etf | $304,000 | +8.6% | 30,000 | 0.0% | 0.00% | 0.0% | |
WTI | W & T OFFSHORE INC | $121,000 | +27.4% | 21,787 | 0.0% | 0.00% | 0.0% | |
VALPQ | VALARIS PLC | $174,000 | +35.9% | 26,572 | 0.0% | 0.00% | 0.0% | |
MGRC | MCGRATH RENTCORP | $69,000 | +9.5% | 900 | 0.0% | 0.00% | – | |
MGEN | MIRAGEN THERAPEUTICS INC | $48,000 | -34.2% | 99,691 | 0.0% | 0.00% | – | |
BYND | BEYOND MEAT INC | $8,000 | -46.7% | 100 | 0.0% | 0.00% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-02-14
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
SPDR S&P 500 ETF TR | 41 | Q2 2024 | 8.3% |
CME GROUP INC | 41 | Q2 2024 | 0.3% |
AMAZON COM INC | 39 | Q2 2024 | 3.2% |
META PLATFORMS INC | 38 | Q1 2024 | 2.2% |
XENON PHARMACEUTICALS INC | 38 | Q2 2024 | 0.4% |
CSX CORP | 37 | Q2 2024 | 1.3% |
BUNGE LIMITED | 37 | Q2 2023 | 1.5% |
VULCAN MATLS CO | 37 | Q2 2024 | 0.9% |
BERRY PLASTICS GROUP INC | 37 | Q1 2024 | 0.8% |
GENERAL MTRS CO | 36 | Q2 2024 | 1.1% |
View Point72 Asset Management, L.P.'s complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
Sphere Entertainment Co. | June 24, 2024 | 1,560,170 | 5.5% |
UroGen Pharma Ltd. | June 24, 2024 | 2,569,826 | 6.2% |
Olema Pharmaceuticals, Inc. | June 14, 2024 | 3,225,250 | 5.7% |
MARAVAI LIFESCIENCES HOLDINGS, INC. | June 10, 2024 | 4,481,050 | 3.4% |
Rapid7, Inc. | May 21, 2024 | 3,121,415 | 5.0% |
Corvus Pharmaceuticals, Inc. | May 09, 2024 | 17,050,384 | 9.9% |
Avid Bioservices, Inc. | April 26, 2024 | 3,226,006 | 5.1% |
SUTRO BIOPHARMA, INC. | April 05, 2024 | 5,791,505 | 7.7% |
Fox Corp | March 26, 2024 | 12,046,118 | 5.0% |
LENZ Therapeutics, Inc. | March 25, 2024 | 864,942 | 3.4% |
View Point72 Asset Management, L.P.'s complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
13F-HR/A | 2024-09-16 |
SC 13G | 2024-09-05 |
N-PX | 2024-09-03 |
13F-HR/A | 2024-08-19 |
13F-HR | 2024-08-14 |
SC 13G | 2024-07-02 |
SC 13G | 2024-06-24 |
SC 13G | 2024-06-24 |
SC 13G | 2024-06-14 |
SC 13G | 2024-06-10 |
View Point72 Asset Management, L.P.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.